Description
The CD43 antibody identifies a cell surface glycoprotein with a molecular weight of 95/115/135 kDa, contingent upon the degree of glycosylation, known as CD43 (leukosialin, sialophorin, or leukocyte sialoglycoprotein). CD43 is demonstrated to be expressed on all thymocytes, T-cells, and endothelial cells. CD43 may assist in differentiating extranodal marginal zone B-cell lymphoma from other reactive skin conditions. The CD43 antibody is effective in facilitating the identification and categorization of T-cell malignancies and ow-grade B-cell lymphomas.
